Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists
ACPE Activity Number: 0204-0000-22-584-H01-P
Release Date: Sept 28, 2022
Expiration Date: Sept 28, 2025
Activity Type: Knowledge-based
CE Credits: 1.0 contact hour, (0.10 CEU)
Activity Fee: Member – Free / Non-Member – Not Available
This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.
This webinar is focused on discussing new literature on the use of direct-acting oral anticoagulants (DOACs) in the pediatric population. Recent Food and Drug Administration (FDA) approvals of both agents and dosage forms have created questions about which agents are optimal for use in which patient populations. This webinar will present the most up-to-date information and include clinical pearls and case-based application to engage attendees and provide tangibile clinical takeaways for practical use of these agents.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
After completing this activity, the learner should be able to…
Identify an appropriate DOAC and dosage form based on patient characteristics.
Discuss the literature for use of DOACs in pediatric patients.
List counseling points and practical tips for use of DOACs in pediatric patients.
Introduction and Announcements
Questions, Answers, and Discussion
Clinical Pharmacy Specialist
St. Louis Children’s Hopsital
St. Louis, MO
Caroline M. Sierra, PharmD, BCPPS
Associate Professor of Pharmacy Practice
Loma Linda University School of Pharmacy
Loma Linda, CA
M. Petrea Cober, PharmD, BCNSP, BCPPS, FASPEN
Clinical Pharmacy Specialist
NICU, Akron Children’s Hospital
Pharmacy Practice, Northeast Ohio Medical University
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.